BCPEM
Bain Capital Public Equity Management Portfolio holdings
AUM
$1.03B
1-Year Return
30.54%
This Quarter Return
+8.99%
1 Year Return
+30.54%
3 Year Return
+135.1%
5 Year Return
+224.71%
10 Year Return
–
AUM
$1.39B
AUM Growth
-$84.3M
(-5.7%)
Cap. Flow
-$166M
Cap. Flow
% of AUM
-11.97%
Top 10 Holdings %
Top 10 Hldgs %
62.98%
Holding
76
New
13
Increased
8
Reduced
21
Closed
21
Top Buys
| 1 |
Caterpillar
CAT
|
$88.6M |
| 2 |
FDC
First Data Corporation
FDC
|
$68.3M |
| 3 |
Novartis
NVS
|
$30.7M |
| 4 |
AABA
Altaba Inc. Common Stock
AABA
|
$27.2M |
| 5 |
Lennox International
LII
|
$22.8M |
Top Sells
| 1 |
DocuSign
DOCU
|
$53.6M |
| 2 |
Gartner
IT
|
$48.1M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
$41M |
| 4 |
Schlumberger
SLB
|
$34.3M |
| 5 |
Coca-Cola Europacific Partners
CCEP
|
$31.1M |
Sector Composition
| 1 | Technology | 38.04% |
| 2 | Industrials | 26.38% |
| 3 | Consumer Discretionary | 14.42% |
| 4 | Healthcare | 11.03% |
| 5 | Communication Services | 6.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
FTCH
26
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
| $13.6M | 0.96% |
+500,000
| New | +$13.6M |
|
|
27
Coca-Cola Europacific Partners
CCEP
$40.4B
| $13M | 0.92% |
286,356
-683,248
| -70% | -$31.1M |
|
|
GBT
28
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $12.2M | 0.86% |
322,316
+180,756
| +128% | +$6.87M |
|
|
CLDR
29
DELISTED
Cloudera, Inc.
CLDR
| $12.1M | 0.86% |
686,813
-516,861
| -43% | -$9.12M |
|
30
Capital One
COF
$142B
| $11.9M | 0.84% |
124,856
-159,600
| -56% | -$15.2M |
|
31
ATI
ATI
$10.7B
| $11.3M | 0.8% |
382,698
-37,138
| -9% | -$1.1M |
|
|
GSAH.U
32
DELISTED
GS Acquisition Holdings Corp. Units, each consisting of one share of Class A common stock and one-th
GSAH.U
| $10.4M | 0.73% |
1,000,000
| – | – |
|
|
33
Gartner
IT
$18.6B
| $10.2M | 0.72% |
64,162
-303,334
| -83% | -$48.1M |
|
34
Salesforce
CRM
$239B
| $10.1M | 0.71% |
63,327
| – | – |
|
35
Sea Limited
SE
$113B
| $9.73M | 0.69% |
703,536
+515,334
| +274% | +$7.13M |
|
36
Hubbell
HUBB
$23.2B
| $8.67M | 0.61% |
+64,887
| New | +$8.67M |
|
37
Fortive
FTV
$16.2B
| $7.67M | 0.54% |
108,788
-245,528
| -69% | -$17.3M |
|
|
TBIO
38
DELISTED
Translate Bio, Inc. Common Stock
TBIO
| $7.39M | 0.52% |
738,543
-236,300
| -24% | -$2.36M |
|
|
39
Schlumberger
SLB
$53.4B
| $6.97M | 0.49% |
114,482
-563,142
| -83% | -$34.3M |
|
40
Liberty Media Series C
FWONK
$25.2B
| $6.38M | 0.45% |
177,405
-131,686
| -43% | -$4.74M |
|
41
Meta Platforms (Facebook)
META
$1.89T
| $5.64M | 0.4% |
34,282
-185,840
| -84% | -$30.6M |
|
|
IMDZ
42
DELISTED
Immune Design Corp.
IMDZ
| $3.93M | 0.28% |
1,139,944
-81,424
| -7% | -$281K |
|
43
Dover
DOV
$24.4B
| $1.41M | 0.1% |
+15,953
| New | +$1.41M |
|
44
Dayforce
DAY
$10.9B
| $528K | 0.04% |
+12,565
| New | +$528K |
|
45
Nutanix
NTNX
$18.7B
| $207K | 0.01% |
+4,834
| New | +$207K |
|
46
Curis
CRIS
$21M
| $163K | 0.01% |
4,589
-328
| -7% | -$11.7K |
|
47
AbbVie
ABBV
$375B
| – | – |
0
| – | – |
|
48
Baker Hughes
BKR
$44.9B
| – | – |
0
| – | – |
|
49
BioMarin Pharmaceuticals
BMRN
$11.1B
| – | – |
-59,389
| Closed | -$5.59M |
|
|
CLLS
50
Cellectis
CLLS
$269M
| – | – |
-109,503
| Closed | -$3.1M |
|